BioVentrix Announces Ralph Stephan von Bardeleben, MD, as Co- Principal Investigator of the REVIVE-HF Clinical Trial

Press/Media

Period3 Mar 2020

Media coverage

1

Media coverage

  • TitleBioVentrix Announces Ralph Stephan von Bardeleben, MD, as Co- Principal Investigator of the REVIVE-HF Clinical Trial
    Media name/outletIndia Pharma News
    Country/TerritoryIndia
    Date3/03/20
    PersonsGregg Stone
View all 1
View less